CROI 2019 Abstract eBook

Abstract eBook

Keyword Index

KEYWORD INDEX

3D collagen matrix 221 90-90-90 UNAIDS targets 1091

Breastfeeding 769, 775, 788 Bridging population 835 Broadly neutralizing antibodies ( BnAb) 45, 76, 100, 145, 296, 305, 311, 340, 356, 358 Burkitt 292 Cabotegravir 34, 139, 140, 470, 473, 489, 545, 549, 969 Calcium 187, 688 Cameroon 1009 Cancer 27, 283, 285, 286, 287, 288, 289, 290, 316, 565, 818 Cancer screening 15, 283, 290 Cannabis 459 Capsid 71, 72, 73, 170, 480 Cardiovascular Disease 634, 666, 813 Cardiovascular disease risk 32, 128, 570, 639, 640, 645, 647, 655, 663, 667, 676, 680, 1068 Cardiovascular health 33, 642 Care continuum 898, 912, 952, 1023, 1029, 1036, 1038, 1039, 1043, 1044, 1053, 1057, 1062, 1066, 1068 Care engagement 1034, 1025 Care patterns 881, 1036 Care retention 1036 Carotid intima-media thickness 644 cART 443, 460, 1015 cART response 523 Cascade 977, 1066 Cascade of care 98, 722, 1024, 1025, 1036, 1043, 1045, 1047, 1051 Case management 580 Cathepsin B 691 CD4 dynamics 246 CD4 evolution 503 CD4 percentage 246 CD4 T cell 90, 150, 167, 180, 181, 240, 287, 314, 890, 1023, 1033, 130, 332, 342, 347, 512 • Reconstitution 325, 395, 523 • Response 299 CD64 716 CD69 684 CD8 suppression 376 CD8 T cells 134, 200, 271, 313, 314, 315, 361, 390, 508 Cell • Activation 427 • Subsets 684 • Turnover 243 CD4/CD8 cell ratio 35, 285, 492, 808 Cellular factors/cytokines 213 Cellular metabolism 248, 315 Cellular proliferation 315 Central nervous system (CNS) 122, 391, 427, 428, 436, 438, 439, 446, 447, 449, 476, 1012 Central nervous system impairment 407 Cerebral small vessel disease 453 Cerebrospinal fluid (CSF) 125, 126, 391, 416, 436, 446, 447, 474, 476, 1012 Cerebrospinal fluid viral escape 447, 450 Cervical cancer 279 Cervical cancer prevention 283, 284 Cervical cancer screening 283, 1066 Cervical cancer treatment 278 Cervical intraepithelial neoplasia 14, 280, 284 • Sorting 330 • Subsets 382 • Surface 177 Cell-associated HIV DNA 362 Cell-associated RNA 389, 427 Cell-to-cell transmission 168, 204, 222 Causal inference 712 Cause of death 286 Cause-specific mortality 286 CCR5 266, 486 CCR5 antagonist-resistant HIV-1 484 CCR5 delta32 mutation 29, 394 CCR5 expression 772 CD32 343, 346 CD38 263 CD4 cell monitoring 148, 149

728, 743, 747, 749, 753, 754, 755, 761, 799, 806, 824, 906, 909, 911, 917, 919, 938, 1010, 1016, 1017, 1022, 1023, 1033, 1037, 1041, 1042, 1045, 1047, 1059, 1073, 1078, 1087, 1089, 1092 ART coverage 94 ART effectiveness 540 ART optimization 830 ART retention 510 Antiretroviral therapy eligibility expansion 1016 Antiretroviral therapy uptake 910, 1016 Antiretroviral treatment 797, 1034 Antiretroviral treatment initiation 521 Antisense protein ASP 177, 179 Antisense transcript AST 378 Antiviral activity 28 Anxiety 917 Apoptosis 264, 612 Activated partial thromboplastin time (APTT) Test 638 Array 277 Arterial inflammation 645 Assisted partner services (aPS) 892 Atherosclerosis 631, 642, 644, 648 Atherosclerosis progression 635 Attachment inhibitor 548 Australia 577 Automated gating 318 Autophagy 691, 823 Avidity 76, 938 Azithromycin 966, 1011 B cell 300, 307, 308 B cell responses 311, 312, 801 Bacterial infections 48 Bacterial products 245 Bacterial translocation 202 Bacterial vaginosis 998, 999, 1004 Baltic states 865 Bangkok 599 Bariatric surgery 678 Barriers 573 Barriers to HIV care 908, 913 Bcl-2 family antagonist 362 Bedaquiline 84, 742 Behavioral 837 Behavioral interventions 921, 1040, 1041 Behavioral risk factors 921 Birth anthropometrics 751 Birth defect 743, 744, 747, 748 Birth outcomes 746, 749 Birth testing 779, 780 Bispecific antibodies 76 Bisulfite Sequencing 388 Black MSM 954 Blips 522 Blood tested 718 Blood-brain barrier 459 Body composition 682 Body mass index 672, 675 Bone 687, 816 Bone disease 30, 686, 816 Bone mineral density 519, 689, 946 Boosting 693 Botswana 95, 505, 530, 826, 836, 875 Brain 432, 438, 439, 452, 453, 474 Brazil 909, 1022, 1071 Breast cancer 16 Breast milk 757 Breast-milk transmission 800 Bictegravir 46, 143, 474, 502, 549, 550, 551, 552, 553 Biomarker 261, 267, 334, 411, 412, 415, 422, 459, 716 Arterial stiffness 646 ARV Resistance 448 Asia 871 Asp expression 179 Asp RNA sequencing 179 Asp transcript 179 Assay 306, 557 Assembly 539

Abacavir 639, 694 Acceptability 997 Accessory proteins 374

Accidental drug overdose 881 Acquired drug resistance 536 Active tuberculosis 716, 733 Acute hepatitis C 85, 576, 585, 594 Acute HIV infection 107, 199, 298, 300, 350, 403, 404, 409, 416, 444, 450, 457, 521, 522, 806, 847, 1055, 1075 ADCC 262, 310, 323, 357, 358 Addiction 953 Additional boost 293 Adenosine 207 Adherence 79, 462, 463, 464, 496, 510, 511, 513, 626, 766, 907, 946, 947, 985, 986, 987, 992, 994, 995, 1041, 1046, 1061, 1078 Adipose tissue 676, 681, 683, 684 Adolescent sexual minority males 920, 1083 Adolescents 46, 795, 810, 811, 812, 813, 817, 821, 822, 920, 932, 964, 993, 994, 995, 1004, 1076, 1080 Adults and adolescents 531 Advanced glycation end product (AGE) 656

Advanced HIV disease 151, 710 Adverse effects of HAART 696 Adverse events 493, 985 Adverse pregnancy outcomes 41 Africa 20, 92, 150, 735, 764, 1032, 1053

African American 696 Age distribution 1089 Age of onset 1067 Aging 254, 255, 258, 418, 424, 437, 467, 662, 664, 699, 701, 703, 899, 1065, 1067 AGYW 831 AIDS 706, 909 AIDS events 287 AIDS Indicator survey 837

AIDSVAX B/E 293 Alcohol 612, 1044 Alcohol use disorder 665 Algorithm 922 Allosteric integrase inhibitors 75 Alpha 4 beta 7 383, 970 Alveolar macrophages 214

Alzheimer 415 Anal cancer 281 Anal HSIL 276, 281 Analytic treatment interruption 25, 307, 309, 340, 350, 389, 393, 402, 403 Anatomic compartments 327 Anemia 791 Animal model 297, 312 Anterior cingulate cortex 457 Anthropometric 794 Anti-ASP antibodies 177 Anti-PD-L1 302 Antibiotic prophylaxis 232 Antibiotics 854 Antibodies 28, 251, 262, 310, 311, 464, 770, 771, 943 Antibody effector functions 28 Antibody glycosylation 304 Antibody response 220 Antibody-dependent cell-mediated cytotoxicity 251, 262, 306, 771

Keyword Index

Anticoagulant therapy 641 Antigen detection assay 710 Antigen-presenting cells 259 Antigen-specific responses 220, 308, 943 Antigen/antibody assays 312 Antioxidant response 431 Antiretroviral drugs 435, 465, 475, 499, 534, 684 Antiretroviral efficacy evaluation 499

Antiretroviral therapy (ART) 39, 152, 217, 241, 242, 248, 274, 308, 315, 317, 322, 325, 341, 403, 409, 413, 416, 428, 436, 439, 489, 479, 494, 495, 498, 499, 503, 508, 512, 515, 518, 520, 521, 525, 527, 538, 547, 553, 641, 652, 657, 671, 679, 681, 690, 698,

CROI 2019 459